Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinically relevant differences between antipsychotic compounds.

T Silverstone1

  • 1Medical College of St Bartholomew's Hospital, London, United Kingdom.

Acta Psychiatrica Scandinavica. Supplementum
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drugs and driving.

British journal of clinical pharmacology·2012
Same author

Menstrual cycle effects on the action of buspirone on food intake in healthy female volunteers.

Journal of psychopharmacology (Oxford, England)·2012
Same author

A double-blind placebo-controlled study of rolipram in depressed in-patients.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Neurochemical and psychoanalytical approaches to mania.

Proceedings of the Royal Society of Medicine·2010
Same author

Sumatriptan challenge in bipolar patients with and without migraine: a neuroendocrine study of 5-HT1D receptor function.

International clinical psychopharmacology·2002
Same author

Serotonin and bipolar disorder.

Journal of affective disorders·2001
Same journal

Use of psychotropic drugs during pregnancy and breast-feeding.

Acta psychiatrica Scandinavica. Supplementum·2015
Same journal

Getting depression clinical practice guidelines right: time for change?

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

Manipulating melatonin in managing mood.

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

Chronobiology of mood disorders.

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

It is time we managed depression: the emerging role of chronobiology. Preface.

Acta psychiatrica Scandinavica. Supplementum·2013
Same journal

Lifestyle management of unipolar depression.

Acta psychiatrica Scandinavica. Supplementum·2013
See all related articles

Antipsychotic drugs for schizophrenia primarily work by blocking dopamine receptors. Differences in side effects, potency, and pharmacokinetics, like selective D2 blockers, guide treatment choices based on patient factors and psychopathology.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Psychiatry

Background:

  • Antipsychotic medications are the cornerstone of schizophrenia treatment.
  • Current antipsychotics share dopamine receptor blockade as a common mechanism of action.
  • Variations in drug properties influence clinical efficacy and side effect profiles.

Purpose of the Study:

  • To review the commonalities and differences among available antipsychotic drugs for schizophrenia.
  • To highlight the role of dopamine receptor blockade in antipsychotic effects.
  • To discuss how pharmacodynamic and pharmacokinetic variations impact drug selection.

Main Methods:

  • Review of pharmacological properties of existing antipsychotic drugs.
  • Analysis of dopamine receptor blockade as a shared mechanism.

Related Experiment Videos

  • Comparison of substituted benzamides (e.g., sulpiride, remoxipride) as selective D2 receptor blockers.

    • Main Results:

    • All antipsychotics block dopamine receptors, underpinning their therapeutic effects.
    • Significant differences exist in side effect profiles, potency, and pharmacokinetics among these drugs.
    • Substituted benzamides demonstrate high selectivity for D2 receptors, offering clinical advantages.

    Conclusions:

    • The choice of antipsychotic depends on psychopathology, treatment goals, and patient characteristics.
    • Pharmacological specificity, such as selective D2 blockade, is crucial for optimizing schizophrenia treatment.
    • Understanding drug variations is key to personalized antipsychotic therapy.